Atlas Trials

Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia

Clinical trial NCT02730195 · TERMINATED

Trial details

NCT number
NCT02730195
Sponsor
Emory University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Myelogenous Leukemia, BCR-ABL1 PositiveRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Start date
2016-05-01
Primary completion
2018-07-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.